Molecular imaging in biomedical research

Current Science

Volumn 92, Issue 8, 2007, Pages 1061-1070

  Jagannathan, N R ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Cancer; Diagnosis; Molecular imaging; Molecular targets; Treatment

Indexed keywords

EID: 34248379104     PISSN: 00113891     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Thakur, M. and Lentle, B. C., Report of a summit on molecular imaging. Radiology, 2005, 236, 753-755.
2. Phelps, M. E. (ed.), PET: Molecular Imaging and its Biomedical Application, Springer, New York, 2004.
3. Wahl, R. L. (ed.), Principles and Practice of Position Emission Tomography, Lippincott Williams & Wilkins, Philadelphia, 2004.
4. Chatziioannoce, A. F., Instrumentation for molecular imaging in pre-clinical research. Proc. Am. Thorac. Soc., 2005, 2, 533-536.
5. Jagannathan, N. R. (ed.), Recent Advances in MR Imaging and Spectroscopy, Jaypee, New Delhi, 2005.
6. Jagannathan, N. R. (ed.), Biomedical Magnetic Resonance: Proceedings of the International Workshop, Jaypee, New Delhi, 2005.
7. Stark, D. and Bradley, W., Magnetic Resonance Imaging, Mosby, New York, 1998.
8. Sharma, U. and Jagannathan, N. R., Potential of in vivo MRS in medicine. Proc. Indian Natl. Sci. Acad., 2004, 70, 555-577.
9. Danielsen, E. R. and Ross, B. D., Magnetic Resonance Spectroscopy Diagnosis of Neurological Diseases, Marcel Dekker, New York, 1999.
10. Bremer, C. and Weissleder, R., In vivo imaging of gene expression: MR and optical technologies. Acad. Radiol., 2001, 8, 15-23.
11. Gremlich, H. U. and Yan, B. (eds), Biological Applications of Infrared Micro-spectroscopy, Marcel Dekker, New York, 2001.
12. Diem, M. et al., A decade of vibrational micro-spectroscopy of human cells and tissue (1994-2004). Analyst, 2004, 129, 880-885.
13. Jackson, M. and Mantsch, H. H., Pathology by infrared and Raman spectroscopy. In Handbook of Vibrational Spectroscopy (eds Chalmers, J. M. and Griffths, P. R.), John Wiley, UK, 2002, vol. 5, pp. 3227-3245.
14. Tearney, G. J. et al., In vivo endoscopic optical biopsy with optical coherence tomography. Science, 1997, 276, 2037-2039.
15. Chance, B., Near-infrared images using continuous, phase modulated, and phased light with quantization of blood and blood oxygenation. Ann. N. Y. Acad. Sci., 1998, 838, 29-45.
16. Villringer, A. and Chance, B. Non-invasive optical spectroscopy and imaging of human brain function. Trends Neurosci., 1997, 20, 435-442.
17. Matthaus, C. et al., Raman and infrared microspectral imaging of mitotic cells. Appl. Spectrosc., 2006, 60, 1-8.
18. Sadikot, R. T. and Blackwell, T. S., Bio-luminescence imaging. Proc. Am. Thorac. Soc., 2005, 2, 537-540.
19. Luker, G. D. and Piwnica-Worms, D., Beyond the genome: Molecular imaging in vivo with PET and SPECT. Acad. Radiol., 2001, 8, 4-14.
20. Li King, C. P., Special issue: Molecular imaging. J. Magn. Reson. Imaging, 2002, 16.
21. Basilion, J. P., Improvement of MRI probes to allow efficient detection of gene expression. Bioconjugate Chem., 2000, 11, 941-946.
22. Rudin, M. and Weissloder, R., Molecular imaging in drug-discovery and development. Nature Rev., 2003, 2, 123-131.
23. Jaffer, F. A., Libbey, P. and Weissleder, R., Molecular and cellular imaging of atherosclerosis. Emerging applications. J. Am. Coll. Cardiol., 2006, 47, 1328-1338.
24. Attili, A. K. and Casacde, P. N., CT and MRI of coronary artery disease: Evidence-based review. AJR Am. J. Roentgenol. (Suppl.), 2006, 187, S483-S499.
25. Price, P., Molecular imaging to improve radiotherapy. Radiother. Oncol., 2006, 78, 233-235.
26. Leong, T., Everitt, C. and Yuen, K. A., A prospective study to evaluate the impact of FDG-PET on CT-based radiotherapy treatment planning for oesophageal cancer. Radiother. Oncol., 2006, 78, 254-261.
27. D'Amico, A. V., Debruyne, F., Huland, H. and Richie, J. P., Innovative treatment for clinically localized adenocarcinoma of the prostate: The future role of molecular imaging. Prostate, 1999, 41, 208-212.
28. Jagannathan, N. R. et al., Evaluation of total choline from in vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer. Br. J. Cancer, 2001, 84, 1016-1022.
29. Kumar, M. et al., Monitoring the therapeutic response of locally advanced breast cancer patients: Sequential in vivo proton MR spectroscopy study. J. Magn. Reson. Imaging, 2006, 24, 325-332.
30. Gimi, B. et al., Molecular imaging of cancer; application of MR methods. Proc. IEEE, 2005, 93, 784-799.
31. Frank, F. A. et al., Methods for magnetically labeling stem and other cells for detection by in vivo MR. Cytotherapy, 2004, 6, 621-625.
32. Lanza, G. M. et al., MR molecular imaging with nanoparticles. J. Nucl. Cardiol., 2004, 11, 733-743.
33. Louie, A. Y. et al., In vivo visualization of gene expression using MRI. Nature Biotechnol., 2000, 18, 321-325.
34. 1H MRSI in patients with abnormal digital rectal examination or raised PSA level of 4-10 mg/ml. NMR Biomed., 2006, 20, 11-20.
35. Hakumaki, J. M. and Liimatainen, T., Molecular imaging of apoptosis in cancer. Eur. J. Radiol., 2005, 56, 143-153.
36. Wood, B. R. et al., Fourier transform infrared spectral mapping of the cervical transformation zone, and dysplastic squamous epithelium. Gynecol. Oncol., 2004, 93, 59-68.
37. Romeo, M. J. and Diem, M., Infrared spectral imaging of lymph nodes: Strategies for analysis and artifact reduction. Vib. Spectrosc., 2005, 38, 115-119.
38. Haglurn, M. M., Berger, M. S. and Hochmann, D. W., Enhanced optical imaging of human gliomas and tumour margins. Neurosurgery, 1996, 38, 308-317.